Quick Summary

Flammulina velutipes, commonly known as the enoki mushroom, is an edible Basidiomycete fungus valued both for its nutritional content and potential therapeutic properties. Preclinical and limited in vivo studies suggest it may have neuroregenerative effects, help mitigate chemotherapy-induced intestinal injury, promote testosterone production in animal models, and possess antioxidant, anti-inflammatory, and immunomodulatory activities. However, specific human clinical data are currently lacking, and further research is needed to establish its efficacy and safety in humans.

What is it?

Enoki mushroom (Flammulina velutipes) is a widely consumed edible mushroom, characterized by its long, thin white stems and small caps. It belongs to the Basidiomycete group of fungi and is cultivated and eaten in various cuisines worldwide. Beyond nutrition, it has been studied for various biological activities related to health.

Traditional Uses

Traditionally, enoki mushrooms have been used primarily as a food source. Although common in culinary applications, their use in traditional medicine is less well documented compared to other medicinal mushrooms. However, mushrooms including Flammulina species have a history of being used in folk medicine, often for immune support and general health maintenance.

Active Compounds

Enoki mushrooms contain various bioactive compounds such as polysaccharides, adenosine, and possibly other antioxidants. Adenosine, identified as one active component, has been studied for its role in promoting testosterone production in animal models. Polysaccharides found in enoki are believed to contribute to its immunomodulatory and antioxidant effects.

Potential Benefits with Evidence Levels

  • Potential neuroregenerative effects in peripheral nerve injury
    Evidence Level: Animal studies, systematic review of in vivo studies
    Details: Animal research indicates that aqueous extracts of Flammulina velutipes may promote nerve regeneration, enhancing Schwann cell migration through FGF-2 signaling and MAPK pathways.
  • Mitigation of chemotherapy (5-fluorouracil) induced intestinal injury
    Evidence Level: Animal study
    Details: A mouse model study demonstrated that a brown strain of enoki mushroom helped reduce intestinal mucositis caused by chemotherapy by suppressing inflammation, oxidative stress, and apoptosis while preserving gut barrier integrity.
  • Potential enhancement of testosterone production and Leydig cell function
    Evidence Level: Animal in vivo and in vitro studies
    Details: Administration of enoki ethanolic extract or its active compound adenosine increased testosterone production in mouse models with cisplatin-induced impairment and fatigue, suggesting possible benefits related to aging and fatigue.
  • Antioxidant, anti-inflammatory, and immunomodulatory potential
    Evidence Level: In vitro and animal studies; extrapolated from edible mushroom literature
    Details: Like many edible mushrooms, Flammulina velutipes likely contains bioactive polysaccharides that contribute to general antioxidant and immune-modulating effects, though specific human clinical evidence is not currently available.

Side Effects

There are no documented adverse effects specifically linked to consumption or extract use of Flammulina velutipes in the available preclinical or translational studies. General mushroom research reports mild side effects in some species, but none are established for enoki specifically. Clinical safety data are currently limited.

Drug Interactions

No information is available regarding potential drug interactions involving Flammulina velutipes or its extracts. Caution is advised when combining with medications until more evidence is available.

Who Should Avoid It?

Specific contraindications for Flammulina velutipes have not been reported. However, due to a lack of safety data, pregnant and breastfeeding women should avoid its use or consult a healthcare professional before consumption. Individuals with mushroom allergies should also avoid enoki mushrooms.

Evidence Limitations

  • Most evidence is derived from in vitro and animal studies; human clinical trials are lacking.
  • Research specifically on Flammulina velutipes is limited compared to other medicinal mushrooms.
  • Mechanistic insights and identification of bioactive compounds require further validation in human studies.
  • Safety, adverse effects, drug interactions, and contraindications have not been systematically investigated in clinical settings.
  • Current evidence on health benefits is preliminary and does not justify clinical recommendations.

References

Last Reviewed

April 2024


Disclaimer: This information is provided for educational purposes only and is not intended as medical advice. Always consult a qualified healthcare professional before starting any new dietary supplement or treatment, especially if you are pregnant, breastfeeding, have existing health conditions, or are taking medications.